ResearcherUniversitätsmedizin GöttingenActive in the last 2 years
Argyris Papantonis
Matched on ORCID iD 0000-0001-7551-1073; OpenAlex author ID A5026125772. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 5
- Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. Last author DOI 10.1016/j.celrep.2026.117649↗
- Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12943-026-02628-3↗
- Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. Co-author DOI 10.1038/s41467-024-55330-7↗
- A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer. Co-author DOI 10.1093/nargab/lqae057↗
- TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer. Co-author DOI 10.1038/s43018-021-00258-w↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Elisabeth Heßmann · 4 shared papers, 2021–2026 · strength 0.68
- Paper A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer. DOI 10.1093/nargab/lqae057↗
- Paper Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma. DOI 10.1186/s12943-026-02628-3↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Adi Danieli‐Mackay · 3 shared papers, 2021–2026 · strength 0.52
- Paper Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. DOI 10.1016/j.celrep.2026.117649↗
- Paper A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer. DOI 10.1093/nargab/lqae057↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Shiv K. Singh · 3 shared papers, 2021–2026 · strength 0.50
- Paper Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. DOI 10.1016/j.celrep.2026.117649↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Lukas Klein · 3 shared papers, 2021–2026 · strength 0.50
- Paper Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. DOI 10.1016/j.celrep.2026.117649↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Volker Ellenrieder · 3 shared papers, 2021–2025 · strength 0.49
- Paper A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer. DOI 10.1093/nargab/lqae057↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Gabriela Salinas · 2 shared papers, 2024–2026 · strength 0.43
- Emre Taylan Duman · 2 shared papers, 2024–2026 · strength 0.43
- Tiago De Oliveira · 2 shared papers, 2026 · strength 0.41
- Lena‐Christin Conradi · 2 shared papers, 2026 · strength 0.41
- Elisa Espinet · 2 shared papers, 2021–2025 · strength 0.28
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Uday Kishore · 2 shared papers, 2021–2025 · strength 0.28
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Andreas Trumpp · 2 shared papers, 2021–2025 · strength 0.28
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Laura Urbach · 2 shared papers, 2021–2025 · strength 0.28
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Mengyu Tu · 2 shared papers, 2021–2025 · strength 0.28
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Paper TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cance… DOI 10.1038/s43018-021-00258-w↗
- Matthias Dobbelstein · 1 shared paper, 2026 · strength 0.22
- Michael B. Ghadimi · 1 shared paper, 2026 · strength 0.19
- Ulrich Sax · 1 shared paper, 2026 · strength 0.19
- Alexandra Maria Schmitt · 1 shared paper, 2026 · strength 0.19
- Carolin Schneider · 1 shared paper, 2026 · strength 0.19
- Nathalia Luisa Carlos Ferreira · 1 shared paper, 2026 · strength 0.19
- Günter Schneider · 1 shared paper, 2026 · strength 0.19
- Rama Khokha · 1 shared paper, 2025 · strength 0.18
- Muhammad Umair Latif · 1 shared paper, 2025 · strength 0.18
- Barbara T. Grünwald · 1 shared paper, 2025 · strength 0.18
- Kazeera Aliar · 1 shared paper, 2025 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.